Kakkar – Talk Bio

Actionable Insights Powered by AI

Tome Biosciences Halts Operations Amid Financial Strains, CEO Focuses on Strategic Deals

Tome Biosciences, gene editing, layoffs, financial struggles, strategic options, Rahul Kakkar